Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LifeMD, Inc. - Common Stock (NQ:LFMD)

2.770 +0.030 (+1.09%)
Delayed Quote Updated: 10:20 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LifeMD, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
LifeMD (LFMD) Q2 2026 Earnings Call Transcript ↗
Revenue met guidance but profitability targets missed amid strategic restructuring. 
Via The Motley Fool
Topics Earnings
News headline image
LifeMD Q2 Earnings Call Highlights ↗
LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million as elevated customer... 
Via MarketBeat
Topics Earnings
LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss ↗
Via Chartmill
LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide ↗
Via Chartmill
News headline image
LifeMD (LFMD) Q1 2026 Earnings Transcript ↗
LifeMD (LFMD) Q1 2026 Earnings Transcript 
Via The Motley Fool
LifeMD Inc (NASDAQ:LFMD) Stock Falls 13% After Q4 Revenue and Earnings Miss ↗
Via Chartmill
Gapping stocks in Monday's session ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗
The development comes as attention remains on Hims’ longer-term business expansion initiatives. 
Via Stocktwits
News headline image
KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds
KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a... 
Via MarketMinute
News headline image
Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Top movers in Tuesday's session ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
These stocks that are showing activity before the opening bell on Tuesday. ↗
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
LifeMD Inc (NASDAQ:LFMD) Stock Plummets Over 22% After Q3 2025 Earnings Miss ↗
LifeMD stock plunges after Q3 2025 earnings miss analyst estimates on both revenue and EPS, triggering a major sell-off. 
Via Chartmill
Topics Earnings
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
LifeMD Stock Plummets After Q3 Earnings: Here's Why ↗
Here's a look at the details from LifeMD's Q3 earnings report. 
Via Benzinga
News headline image
Novo Nordisk Leans Into Affordability Amid Rising Competition ↗
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout. 
Via Benzinga
News headline image
Earnings Scheduled For November 17, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: LifeMD's Earnings Outlook ↗
 
Via Benzinga
News headline image
Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks
Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>